Published in Alzheimers Dement (Amst) on December 19, 2016
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol (2011) 3.56
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res (2009) 3.31
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement (2010) 3.30
Regulated cleavage of a contact-mediated axon repellent. Science (2000) 3.24
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol (2010) 2.76
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia. Proc Natl Acad Sci U S A (2007) 2.03
The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology (2004) 1.87
Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol (2015) 1.76
Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. Nature (2009) 1.59
Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol (2007) 1.55
Cis- and trans-acting gene regulation is associated with osteoarthritis. Am J Hum Genet (2006) 1.55
Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains. PLoS One (2012) 1.48
RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway. J Cell Sci (2003) 1.47
The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet (2010) 1.41
Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J Neurosci (2009) 1.33
Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms. Hum Mol Genet (2013) 1.32
Structural insight into the zinc finger CW domain as a histone modification reader. Structure (2010) 1.30
Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur J Neurosci (2013) 1.27
Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement (2012) 1.27
EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. J Cell Sci (2009) 1.27
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci (2013) 1.26
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet (2014) 1.17
Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol (2008) 1.16
Clues to CD2-associated protein involvement in cytokinesis. Mol Biol Cell (2005) 1.16
The lysosome and neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) (2009) 1.15
Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes. Immunol Res (2009) 1.10
Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol (2011) 1.08
Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype. Biol Psychiatry (2012) 1.07
Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph. Mol Cell Biol (1988) 1.07
Autophagic/lysosomal dysfunction in Alzheimer's disease. Alzheimers Res Ther (2013) 1.01
Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin (2013) 0.89
EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma. Oncol Rep (2010) 0.89
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 0.89
Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem Biophys Res Commun (2000) 0.88
Association of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a meta-analysis. Arthritis Res Ther (2008) 0.88
ATP-binding Cassette Transporter A7 (ABCA7) Loss of Function Alters Alzheimer Amyloid Processing. J Biol Chem (2015) 0.88
Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31. J Biol Chem (2011) 0.87
Molecular cloning of a third member of the potassium-dependent sodium-calcium exchanger gene family, NCKX3. J Biol Chem (2001) 0.87
Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease. PLoS One (2014) 0.87
Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol Aging (2013) 0.87
Association of Alzheimer's disease GWAS loci with MRI markers of brain aging. Neurobiol Aging (2015) 0.86
A kernel machine method for detecting effects of interaction between multidimensional variable sets: an imaging genetics application. Neuroimage (2015) 0.86
Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study. Lipids (2012) 0.86
Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update. Arch Immunol Ther Exp (Warsz) (2015) 0.84
An essential role for the K+-dependent Na+/Ca2+-exchanger, NCKX4, in melanocortin-4-receptor-dependent satiety. J Biol Chem (2014) 0.83
Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly. Mol Imaging Biol (2009) 0.83
Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D. Gene Ther (2009) 0.83
The effect of reference panels and software tools on genotype imputation. AMIA Annu Symp Proc (2011) 0.83
Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurol Genet (2015) 0.83
Rab GTPases, membrane trafficking and diseases. Curr Drug Targets (2011) 0.83
Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-β protein precursor transgenic mice. J Alzheimers Dis (2013) 0.82
Association of SORL1 gene variants with hippocampal and cerebral atrophy and Alzheimer's disease. Curr Alzheimer Res (2014) 0.82
Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model. Mol Neurodegener (2015) 0.81
Autophagosome-lysosome fusion in neurons requires INPP5E, a protein associated with Joubert syndrome. EMBO J (2016) 0.81
Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology (2016) 0.80
Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. J Alzheimers Dis (2015) 0.80
Understanding the function of ABCA7 in Alzheimer's disease. Biochem Soc Trans (2015) 0.79
Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimers Dement (2015) 0.79
The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity. Hum Mol Genet (2015) 0.78
GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease. Mol Neurobiol (2016) 0.78
Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding. Neurol Genet (2015) 0.77
ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology. J Alzheimers Dis (2016) 0.76
ABCA7 p.G215S as potential protective factor for Alzheimer's disease. Neurobiol Aging (2016) 0.76
Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration. J Alzheimers Dis (2016) 0.76
MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures. Oncotarget (2016) 0.76
Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy. Neurobiol Aging (2015) 0.75
Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers Dis (2017) 0.75